- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02167581
Confrontation Phenotypes and Genotypes of Epithelial Odontogenic Tumors of the Jaws (TEIOS)
Confrontation Phenotypic (Clinical, Radiological, Histological) and Genotypic Epithelial Odontogenic Tumors Isolated or Syndromic Jaws
Systematically compare the phenotype and genotype of epithelial odontogenic tumors in children and adults with a clinical, radiographic, pathologic and molecular level.
Either:
establish an observatory of this multidisciplinary tumor establish a tumor bank annotated scale unparalleled testing pathophysiological hypotheses search for prognostic factors.
Study Overview
Status
Conditions
Detailed Description
This is an observational study with retrospective and prospective parts. In retrospective part be included the Patients followed between 1992 and January 2011.
In prospective part will follow the Patients will be included after the starting of study.
There are 2 centers :
- st center is in the service of Stomatology and Maxillofacial Surgery in the Pitie Salpetriere Hospital.
- nd center is in the service of Maxillofacial Surgery in hospital Armand Trousseau.
Number of patients include in the part retrospective :
Center N°1-300adults Center N°2-90childrens
Number of patients include in the part prospective :
Center N°1- 90 Center N°2- 30
Duration of study is 3 years Duration of inclusion is 32 months Each patient will be followed for 4 months and for further up to 3 years from the first patient included.
We envision a next circuit : obtaining consent, preoperative consultation,surgery, postoperative consultation N°1, postoperative consultation N°2, genetics consultation and monitoring of patients in 6;12;18;24 months from surgery of tumor and limited in 3 years from th 1st patient included.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75013
- Stomatologie et Chirurgie Maxillofaciale - Pitie Salpetriere
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria
- Patient with an osteolytic lesion of the jaws
Patient with epithelial odontogenic tumor:
keratocysts ameloblastoma Pindborg tumor or calcifying (ESWT) Epidermoid (Squamous Odontogenic Tumor SOT) Clear cell (Clear Odontogenic Tumor Cells CCOT)
- Patient monitoring in the period 1992 to January 2011 at the Trousseau Hospital (children) or at the Pitie Salpetriere (adult)
- Patient aged 5 years or more
- Adult patient who had signed informed consent
- Holders of parental authority of minor patient were informed and signed consent
Non inclusion criteria
- Patient with an osteolytic lesion of dental origin inflammatory (adjacent teeth decayed, non-living mortified)
- Patient with a cyst fissure (nasopalatine, symphyseal or globulomaxillary)
- Patient with arteriovenous malformation, vascular
- Patient with cons-indication to MRI
- Patient not affiliated with a social security scheme (beneficiary or assignee)
- Pregnant woman
- Patient in his history of hypersensitivity to salts of gadolinium
- Patient receiving a measure of legal protection
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
epithelial odontogenic tumours
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Phenotypic and genotypic lines connected to the epithelial odontogenic tumours
Time Frame: Month 24 from the surgery date
|
In particular, to define the link between the genotype PTCH1, the size of the tumor, its osteolytic character and the predictive factors of recurrence. Data collection at M6, M12, M18, M24 from the surgery date |
Month 24 from the surgery date
|
Collaborators and Investigators
Investigators
- Principal Investigator: Blandine Ruhin, MD, PhD, Assistance Publique - Hôpitaux de Paris
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P081259
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epithelial Odontogenic Tumours
-
NYU College of DentistryGenentech, Inc.CompletedKeratocystic Odontogenic TumorUnited States
-
GlaxoSmithKlineNo longer available
-
LaNova Medicines LimitedTerminated
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Onyx Therapeutics, Inc.Completed
-
Debiopharm International SATerminatedSolid TumoursKorea, Republic of, United States, Taiwan, Spain, Singapore
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaParexelCompleted
-
AstraZenecaQuintiles, Inc.Completed
-
AstraZenecaRecruitingSolid TumoursAustralia, Korea, Republic of, Germany, United States, Spain, France, Canada, Italy, Austria, Israel, United Kingdom, Denmark, Hungary, Poland, Russian Federation, Ukraine, Brazil